RBC Capital Defending Sarepta Therapeutics (SRPT), 'we believe weakness presents a buying opportunity'
Go back to RBC Capital Defending Sarepta Therapeutics (SRPT), 'we believe weakness presents a buying opportunity'| SAREPTA THERAP (NASDAQ: SRPT) | Delayed: 18.10 -0.32 (1.74%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $18.42 | 52 Week High | $63.73 | |||
| Open | $18.22 | 52 Week Low | $8.00 | |||
| Day High | $18.26 | P/E | N/A | |||
| Day Low | $17.69 | EPS | $-5.69 | |||
| Volume | 1,561,234 | |||||

